CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-20 | Cohen Fred E Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2018-06-20 | ABERCROMBIE GEORGE B Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2018-06-01 | Sheridan William P Senior VP - CMO | Option exercise | +42,112 | $2.58 | $109K | 63,170 |
| 2018-06-01 | Sheridan William P Senior VP - CMO | Sale | −42,112 | $6.30 | $265K | 21,058 |
| 2018-06-01 | Sheridan William P Senior VP - CMO | Option exercise · Emp. Stock Option (Right to Buy) | −42,112 | 0 | ||
| 2018-06-01 | INGRAM ROBERT ALEXANDER Director | Grant or award | +2,916 | $6.43 | $19K | 21,818 |
| 2018-06-01 | Hutson Nancy J Director | Grant or award | +1,555 | $6.43 | $10K | 39,702 |
| 2018-05-17 | Stonehouse Jon P President & CEO | Option exercise | +70,427 | $1.42 | $100K | 725,519 |
| 2018-05-17 | Stonehouse Jon P President & CEO | Option exercise · Emp. Stock Option (Right to Buy) | −70,427 | 297,573 | ||
| 2018-05-15 | Barnes Alane P VP, General Counsel & Corp Sec | Option exercise | +12,500 | $1.42 | $18K | 98,268 |
| 2018-05-15 | Barnes Alane P VP, General Counsel & Corp Sec | Shares withheld for taxes | −3,004 | $5.91 | $18K | 95,264 |
| 2018-05-15 | Barnes Alane P VP, General Counsel & Corp Sec | Option exercise · Emp. Stock Option (Right to Buy) | −12,500 | 8,132 | ||
| 2018-03-06 | Babu Yarlagadda S Senior VP - Drug Discovery | Option exercise | +20,622 | $3.26 | $67K | 120,618 |
| 2018-03-06 | Babu Yarlagadda S Senior VP - Drug Discovery | Shares withheld for taxes | −15,223 | $5.18 | $79K | 105,395 |
| 2018-03-06 | Babu Yarlagadda S Senior VP - Drug Discovery | Option exercise | +9,378 | $3.26 | $31K | 114,773 |
| 2018-03-06 | Babu Yarlagadda S Senior VP - Drug Discovery | Shares withheld for taxes | −5,902 | $5.18 | $31K | 108,871 |
| 2018-03-06 | Babu Yarlagadda S Senior VP - Drug Discovery | Option exercise · Non-Qualified Stock Option | −20,622 | 0 | ||
| 2018-03-06 | Babu Yarlagadda S Senior VP - Drug Discovery | Option exercise · Emp. Stock Option (Right to Buy) | −9,378 | 0 | ||
| 2018-03-01 | INGRAM ROBERT ALEXANDER Director | Grant or award | +3,772 | $4.97 | $19K | 18,902 |
| 2018-03-01 | Hutson Nancy J Director | Grant or award | +2,012 | $4.97 | $10K | 38,147 |
Page 37 of 38 · 750 trades